BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

546 related articles for article (PubMed ID: 9530435)

  • 1. Prostaglandin E receptors in myometrial cells.
    Asbóth G; Phaneuf S; López Bernal AL
    Acta Physiol Hung; 1997-1998; 85(1):39-50. PubMed ID: 9530435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostaglandin E2 activates phospholipase C and elevates intracellular calcium in cultured myometrial cells: involvement of EP1 and EP3 receptor subtypes.
    Asbóth G; Phaneuf S; Europe-Finner GN; Tóth M; Bernal AL
    Endocrinology; 1996 Jun; 137(6):2572-9. PubMed ID: 8641211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of the prostanoid receptor(s) on human blood monocytes at which prostaglandin E2 inhibits lipopolysaccharide-induced tumour necrosis factor-alpha generation.
    Meja KK; Barnes PJ; Giembycz MA
    Br J Pharmacol; 1997 Sep; 122(1):149-57. PubMed ID: 9298541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of expression of matrix metalloproteinase-9 in early human T cells of the HSB.2 cultured line by the EP3 subtype of prostaglandin E2 receptor.
    Zeng L; An S; Goetzl EJ
    J Biol Chem; 1996 Nov; 271(44):27744-50. PubMed ID: 8910368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostaglandin E2 induces Ca2+ release from ryanodine/caffeine-sensitive stores in bovine adrenal medullary cells via EP1-like receptors.
    Shibuya I; Tanaka K; Uezono Y; Ueta Y; Toyohira Y; Yanagihara N; Izumi F; Yamashita H
    J Neurochem; 1999 Nov; 73(5):2167-74. PubMed ID: 10537077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potentiation of aggregation and inhibition of adenylate cyclase in human platelets by prostaglandin E analogues.
    Matthews JS; Jones RL
    Br J Pharmacol; 1993 Feb; 108(2):363-9. PubMed ID: 8448586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of interaction between prostaglandin E2 receptor subtypes in regulating adenylyl cyclase activity in cultured rat dorsal root ganglion cells.
    Wise H
    Eur J Pharmacol; 2006 Mar; 535(1-3):69-77. PubMed ID: 16545798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EP1- and EP3-receptors mediate prostaglandin E2-induced constriction of porcine large cerebral arteries.
    Jadhav V; Jabre A; Lin SZ; Lee TJ
    J Cereb Blood Flow Metab; 2004 Dec; 24(12):1305-16. PubMed ID: 15625406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostaglandin E2 activates EP2 receptors to inhibit human lung mast cell degranulation.
    Kay LJ; Yeo WW; Peachell PT
    Br J Pharmacol; 2006 Apr; 147(7):707-13. PubMed ID: 16432506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostaglandin E2 induces vascular endothelial growth factor secretion in prostate cancer cells through EP2 receptor-mediated cAMP pathway.
    Wang X; Klein RD
    Mol Carcinog; 2007 Nov; 46(11):912-23. PubMed ID: 17427962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of the PGE2 receptor subtype in bovine chondrocytes in culture.
    de Brum-Fernandes AJ; Morisset S; Bkaily G; Patry C
    Br J Pharmacol; 1996 Aug; 118(7):1597-604. PubMed ID: 8842420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Positive and negative regulation of cell proliferation through prostaglandin receptors in NIH-3T3 cells.
    Watanabe T; Satoh H; Togoh M; Taniguchi S; Hashimoto Y; Kurokawa K
    J Cell Physiol; 1996 Nov; 169(2):401-9. PubMed ID: 8908208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EP4/EP2 receptor-specific prostaglandin E2 regulation of interleukin-6 generation by human HSB.2 early T cells.
    Zeng L; An S; Goetzl EJ
    J Pharmacol Exp Ther; 1998 Sep; 286(3):1420-6. PubMed ID: 9732406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostaglandin E receptor subtypes involved in stimulation of gastroduodenal bicarbonate secretion in rats and mice.
    Takeuchi K; Ukawa H; Furukawa O; Kawauchi S; Araki H; Sugimoto Y; Ishikawa A; Ushikubi F; Narumiya S
    J Physiol Pharmacol; 1999 Jun; 50(2):155-67. PubMed ID: 10424714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cloning of a novel human prostaglandin receptor with characteristics of the pharmacologically defined EP2 subtype.
    Regan JW; Bailey TJ; Pepperl DJ; Pierce KL; Bogardus AM; Donello JE; Fairbairn CE; Kedzie KM; Woodward DF; Gil DW
    Mol Pharmacol; 1994 Aug; 46(2):213-20. PubMed ID: 8078484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelin-induced changes of second messengers in cultured human ciliary muscle cells.
    Matsumoto S; Yorio T; Magnino PE; DeSantis L; Pang IH
    Invest Ophthalmol Vis Sci; 1996 May; 37(6):1058-66. PubMed ID: 8631621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of prostaglandin E2 receptors in migration of murine and human breast cancer cells.
    Timoshenko AV; Xu G; Chakrabarti S; Lala PK; Chakraborty C
    Exp Cell Res; 2003 Oct; 289(2):265-74. PubMed ID: 14499627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of prostaglandin receptors EP4 and FP in human lens epithelial cells.
    Mukhopadhyay P; Bhattacherjee P; Andom T; Geoghegan TE; Andley UP; Paterson CA
    Invest Ophthalmol Vis Sci; 1999 Jan; 40(1):105-12. PubMed ID: 9888433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostaglandin E receptor subtypes in cultured rat microglia and their role in reducing lipopolysaccharide-induced interleukin-1beta production.
    Caggiano AO; Kraig RP
    J Neurochem; 1999 Feb; 72(2):565-75. PubMed ID: 9930728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective regulation of RNK-16 cell matrix metalloproteinases by the EP4 subtype of prostaglandin E2 receptor.
    Zeng L; An S; Goetzl EJ
    Biochemistry; 1996 Jun; 35(22):7159-64. PubMed ID: 8679543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.